Pharmacology of the Calcium Antagonist Isradipine Urs T. RüeggRobert P. Hof Short Communication 18 October 2012 Pages: 3 - 9
Isradipine in Hypertension Lennart Hansson Section 2: Clinical Application of Calcium Antagonists 18 October 2012 Pages: 10 - 14
Natriuretic Effects of Calcium Antagonists Alberto ZanchettiGastone Leonetti Section 2: Clinical Application of Calcium Antagonists 18 October 2012 Pages: 15 - 21
Multicentre Isradipine Dose-Confirmation Study in Thai Patients With Hypertension Supachai TanomsupPrapatra TantbirojnKawi Charoenlarp Section 3: Future Clinical Trends 18 October 2012 Pages: 22 - 25
Isradipine in Asian Patients with Hypertension M. ZubairS. KarimS. Hussain Section 3: Future Clinical Trends 18 October 2012 Pages: 26 - 29
Double-Blind Multicentre Isradipine Dose-Confirmation Study in Pakistan S. M. RabMukhtar Azeem MirzaMansoor Ahmed Short Communication 18 October 2012 Pages: 30 - 32
Isradipine Dose-Confirmation Study in Filipino Patients with Mild to Moderate Hypertension Ramon F. Abarquez JrEsperanza I. CabralRafael R. Castillo Section 3: Future Clinical Trends 18 October 2012 Pages: 33 - 37
A Comparison of Antihypertensive Drug Effects on the Progression of Extracranial Carotid Atherosclerosis Richard H. Grimm JrJohn M. FlackMIDAS Research Group Section 3: Future Clinical Trends 18 October 2012 Pages: 38 - 43
Experimental Studies with Isradipine in Stroke André SauterMarkus Rudin Section 3: Future Clinical Trends 18 October 2012 Pages: 44 - 51
Isradipine in Patients with Acute Ischaemic Cerebral Infarction A. AzconaX. Lataste Section 3: Future Clinical Trends 18 October 2012 Pages: 52 - 57
Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women I. IngemarssonD. Wide-SwenssonS. Arulkumaran Short Communication 18 October 2012 Pages: 58 - 59
The Calcium Antagonist Isradipine in the Therapy of Hypertension D. WelzelK. J. Burger Poster Presentations 18 October 2012 Pages: 60 - 64